Hippo/YAP, β-Catenin, and the Cancer Cell: A "Menage a Trois" in Hepatoblastoma

被引：13
|
作者：
Sylvester, Karl G. [1 ,2 ]
Colnot, Sabine [3 ,4 ]
机构：
[1] Stanford Univ, Sch Med, Dept Surg, Hagey Lab Regenerat Med, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[3] Univ Paris 05, Inst Cochin, CNRS, Paris, France
[4] INSERM, Paris, France
来源：
GASTROENTEROLOGY | 2014年 / 147卷 / 03期
关键词：
WNT/BETA-CATENIN; GENETICS; APC;
D O I：
10.1053/j.gastro.2014.07.026
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：562 / 565
页数：5
相关论文
共 50 条
  • [31] Hippo-YAP Signaling Pathway Modulates Stellate Cell Activation in Pancreatic Cancer and Pancreatitis
    Wang, Qiang
    Pandol, Stephen
    Morvaridi, Susan
    GASTROENTEROLOGY, 2015, 148 (04) : S396 - S396
  • [32] ANGIOMOTIN REGULATES PROSTATE CANCER CELL PROLIFERATION BY SIGNALING THROUGH HIPPO-YAP PATHWAY
    Shen, Pengfei
    Zeng, Hao
    Ortiz, Angelica
    Cheng, Chien-Jui
    Lee, Yu-Chen
    Yu, Guoyu
    Lin, Song-Chang
    Yu-Lee, Li-Yuan
    Lin, Sue-Hwa
    JOURNAL OF UROLOGY, 2017, 197 (04): : E1324 - E1324
  • [33] Angiomotin regulates prostate cancer cell proliferation by signaling through the Hippo-YAP pathway
    Zeng, Hao
    Ortiz, Angelica
    Shen, Peng-Fei
    Cheng, Chien-Jui
    Lee, Yu-Chen
    Yu, Guoyu
    Lin, Song-Chang
    Creighton, Chad J.
    Yu-Lee, Li-Yuan
    Lin, Sue-Hwa
    ONCOTARGET, 2017, 8 (06) : 10145 - 10160
  • [34] Clinical potential of the Hippo-YAP pathway in bladder cancer
    Cheng, Xin
    Lou, Kecheng
    Ding, Liang
    Zou, Xiaofeng
    Huang, Ruohui
    Xu, Gang
    Zou, Junrong
    Zhang, Guoxi
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [35] An update on targeting Hippo-YAP signaling in liver cancer
    Liu, Angela M.
    Xu, Zhi
    Luk, John M.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 (03) : 243 - 247
  • [36] YAP/Hippo Pathway and Cancer Immunity: It Takes Two to Tango
    Matthaios, Dimitrios
    Tolia, Maria
    Mauri, Davide
    Kamposioras, Konstantinos
    Karamouzis, Michalis
    BIOMEDICINES, 2021, 9 (12)
  • [37] YAP, TAZ, and Hippo-Dysregulating Fusion Proteins in Cancer
    Driskill, Jordan H.
    Dermawan, Josephine K.
    Antonescu, Cristina R.
    Pan, Duojia
    ANNUAL REVIEW OF CANCER BIOLOGY, 2024, 8 : 331 - 350
  • [38] properties through the Hippo-YAP pathway in prostate cancer
    Jiang, Donggen
    Li, Jun
    Ma, He
    Yan, Binyuan
    Lei, Hanqi
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2025, 22 (02): : 460 - 472
  • [39] Hierarchy of TGFβ/SMAD, Hippo/YAP/TAZ, and Wnt/β-catenin signaling in melanoma phenotype switching
    Luond, Fabiana
    Pirkl, Martin
    Hisano, Mizue
    Prestigiacomo, Vincenzo
    Kalathur, Ravi K. R.
    Beerenwinkel, Niko
    Christofori, Gerhard
    LIFE SCIENCE ALLIANCE, 2022, 5 (02)
  • [40] The role of the Hippo/YAP pathway in cancer drug resistance.
    Bivona, Trever
    MOLECULAR CANCER RESEARCH, 2020, 18 (08) : 17 - 17
12345